Introduction
octurnal enuresis (NE) is a common complaint in urology field and it affects a lot of children around the world 1, 2 . Recurrence and treatment failure represent two main challenges in management of this disorder 3 . The International Children's Continence Society (ICCS) defines enuresis as an intermittent and involuntary passage of urine during sleep in five-year old and more children 4 . Nocturnal enuresis is classified into: Monosymptomatic nocturnal enuresis (MNE) and Nonmonosymptomatic nocturnal enuresis (NMNE). Monosymptomatic nocturnal enuresis means enuresis in children without history of bladder dysfunction or lower urinary tract symptoms (LUTS), it can be further divided into primary and secondary 5 . Primary MSE defined as failure of a child to have adequate time of night dryness 6 . Secondary MSE defined as children with established enuresis after a period of dryness of six months 7 . The incidence rate is different in different age groups; it is estimated at 5 and 15 year old as (15-20%) and (1-2%) respectively 8 . The estimated spontaneous resolution rate is 15% per year 9 . Enuresis appears to involve boys more than girls with 2:1 ratio 10 . Although the cause of NE is unclear, multiple body systems are N thought to be involved, these systems include: the urinary bladder, kidney and brain 5 . Urodynamic studies done during sleep found a significant bladder contraction rate in children with MSE as compared to those without 11 . It is stated that enuretic child have smaller bladder capacity than age matched control 12 . Other study found that the highest endurable bladder capacity was analogous between children with enuresis and controls during day time 13 . So it is useful to describe the bladder as functionally undersized. Normally urine production is decreased at night time to half of that at day time due to the effect of antidiuretic hormone (ADH) 14 . There are multiple proposed mechanisms for nocturnal polyuria in enuretic children and one of them is the effect of ADH circadian rhythm 15 . Other claimed mechanisms for increased urine formation at night may include greater fluid intake at the time before sleeping 16 , increased dietary solute load at evening which leads to increased urine osmolality 17 , abnormal circadian rhythm of glomerular filtration rate 18 , obstructive sleep apnoea and hypoventilation 19 . It is important to know that not all children with enuresis have nocturnal polyuria 20 . In healthy children, bladder distention and contractions are strong factors that induce awakening 21 . Enuretic children are often described as deep sleepers and they also have high threshold arousal and look more confused on awakening 22 . Although NE is a benign condition that may resolve as the child grows up, it may be associated with greater embarrassment and disappointment for the child 23 . Therefore, the goals of treatment are decreasing bed wetting nights, preventing wetting in special situations like sleepover and camping and preventing recurrence of the wetting 24 . Child willing and motivation are essential parts for starting successful treatment 25 . Treatment starts with reassuring and educating both child and parents. Many treatment modalities are attempted like behavioral therapy, alarm devices, medications (Desmopressin, Anticholinergic drugs, Tricyclic antidepressant,) and different combinations of these therapies 26 .
Aim of study
Till now no single effective treatment was prescribed for PMSE, so we design this study to assess the efficacy of available treatment modalities that are commonly used in the outpatient department like behavioral therapy, Desmoperssin, Oxybutynin, and combination of these modalities.
Patients and Method
This study was conducted from March to November 2016; it is a prospective randomized clinical study done for children attending urology outpatient clinic of Basrah General Hospital from Basrah and nearby provinces. The inclusion criteria were children with primary MNE with age from 6 to 14 years old. The exclusion criteria was any history of day time incontinence or lower urinary tract symptoms, neurological diseases, genitourinary system abnormality, urinary tract infection and diabetes mellitus. All patients were subjected to full history, physical examination, urinalysis, blood sugar measurement, and urinary system ultrasonography. After confirmation of the diagnosis of PMNE, the total number of patients was 92. They were divided randomly by simple computer randomization into four groups each 23 cases. Group A received behavioral therapy, Group B given single dose of Desmopressin nasal spray of 20 microgram at night, group C given Oxybutynin 0.2 mg/kg three times daily and Group D given combination of the above treatment modalities. Fourteen patients were lost during followup (group A 4 patients, group B 2 patients, group C 5 patients and group D 3 patients) and the remaining total number was 78. All patients' parents were informed about the drugs taken by their children during the first visit regarding timing and possible side effects. The children were followed up and assessed at 4 and 12 weeks. The parents asked to make a tick in the follow up chart every morning about the wetting status of their child and possible undesirable effects of treatment. 
Results
Demographic characteristics for each group including patient's number, mean age and gender are shown in table I, the final total number of patients was 78. There was no significant difference in the age and sex between the different groups. 
Discussion
This research designed to study the efficacy of behavioral modulations, Desmopressin, Oxybutynin, and the combination of the three treatment options on primary monosymptomatic nocturnal enuresis. The efficacy was assessed by total reduction in number of nights/week, percentage of reduction in wet nights and response rate of different therapeutic modalities according to international continence society (ICCS) values of success. Although behavioral therapy considered first treatment option and its efficacy was mentioned to be better than no treatment 27 , the response found in many studies was variable. A recent study by Erol et al in Turkey showed a full response rate at 1 month and 1 year in 40%, 54% respectively, partial response in 10% and 8% and no response in 52%, 38% 28 . Another study done by Robson showed a full response in 22% and partial response in 39% 29 , also Baeynes found a full response rate in 24% only 30 . In a study on Egyptian children, full response was 35%, partial response was 30% done by Farida in (2015) 31 . However, in this study there is a diversity in results and it reveals no full response rate (0%), partial response in 42% and no response in 57%, this may be explained by the nonadherence of the patients with the instructions given to them owing to different cultural and social background of the families and those children need more visits to the clinic for insuring their family application of and adherence to the given instructions. Also a longer duration of applying the behavioral modulation measures is needed to assess the efficacy of them. It is wisely to ask about the efficacy of behavioral therapy and bladder training, Cederblad (2015) found that these measures not significantly reduce wet nights 32 . With Desmopressin therapy this study shows comparable response rate with many other studies and reviews like T. Naveus et al (2010) with 30% full response and 40% partial response 33 . Also in small number (40 child) study done in Egypt at 2015 response to Desmopressin was 45% respond fully and 25% respond partially 31 . Fai-Nago (2005) found a full response in 31% and partial response in 39% 34 ,While in this study response was 57% fully and 28% partially with slightly more full response, and total response 81% which is also higher than the studies above but lower in study done by G. Bolla (2014 ) that showed 97% response rate 35 . The relapse rate was not assessed in this study owing to short time of follow up and not intended initially. The use of anticholinergic drugs as monotherapy is conflicting and its efficacy is questionable 36 . As mentioned in some studies it can be used in patients with diurnal enuresis or if treatment with DDPVA failed. Anticholinergics can be combined with DDPVA or used alone with response rate range from 47% to 71% 37, 38 . These drugs best used in patients with hyperreflexic and restricted bladder capacity 37 . Although in this study we did not assess bladder capacity, Oxybutynin showed full response rate of 50% and parietal response rates of 33% at 3 months (total response 83%) which is a promising results, these results are nearly similar to a study results done in Iran 2015 Seyfhashemi et al showed 71%response to Oxybutynin at 6 weeks follow up 39 41 . Although we use standard dose of Oxybutynin with Desmopressin and we got good results, Berkenwald (2016) found that increasing dose of Oxybutynin associated with more success than using standard dose 42 , therefore, combination of these drugs preserved to failure of single treatment 38 .
Conclusions and Recommendations
This study results showed a diversity regarding the use of behavioral therapies as these therapies did not effectively treat enuresis and their effectiveness should be asked. The use of Desmopressin is associated with acceptable improvement. Oxybutynin administration showed good results and may be promoted to use as first line single monotherapy for primary nocturnal enuresis and adding Oxybutynin to Desmpressin have a high success rate, but should be used for failure of either above drug monotherapy. We recommend a longer duration of follow up with larger patient's sample.
